Ferhanoglu, B. Et Al. 2022. Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data. 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Louisiana, United States Of America), 6704-6705.

Ferhanoglu, B., Gulbas, Z., Uzay, A., ÖZCAN, M., ÖZKALEMKAŞ, F., Dal, M. S., ... Kalyon, H.(2022). Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data . 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) (pp.6704-6705). Louisiana, United States Of America

Ferhanoglu, Burhan Et Al. "Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 2022

Ferhanoglu, Burhan Et Al. "Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.6704-6705, 2022

Ferhanoglu, B. Et Al. (2022) . "Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.6704-6705.

@conferencepaper{conferencepaper, author={Burhan Ferhanoglu Et Al. }, title={Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data}, congress name={64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Louisiana}, country={United States Of America}, year={2022}, pages={6704-6705} }